The Bottom Line Retatrutide dosing follows a straightforward 12-week titration: 2 mg for four weeks, 4 mg for four weeks, 8 mg for four weeks, then 12 mg maintenance
Retatrutide targets three different receptors: GLP-1 (helps regulate appetite and blood sugar) GIP (supports insulin response) Glucagon (affects energy use and fat metabolism) By targeting all three, the medication delays how fast your stomach digests food, lowers your appetite, and ultimately reduces how much food you eat
But the trial did not measure lean mass versus fat mass in detail
The effects on menstrual cycles can begin within the first few months of treatment
Their products are designed to work synergistically for full-body support, and with subscription options, bundled savings, and a 90-day money-back guarantee, Stonehenge Health is a trusted partner in long-term, proactive wellbeing
[3] As of mid-2025, retatrutide has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for use in the UK or Europe
